LLY

817.59

-1.55%↓

UNH

566.44

+0.03%↑

JNJ

159.98

+0.01%↑

NVO

111.95

+0.05%↑

ABBV

203.23

-0.43%↓

LLY

817.59

-1.55%↓

UNH

566.44

+0.03%↑

JNJ

159.98

+0.01%↑

NVO

111.95

+0.05%↑

ABBV

203.23

-0.43%↓

LLY

817.59

-1.55%↓

UNH

566.44

+0.03%↑

JNJ

159.98

+0.01%↑

NVO

111.95

+0.05%↑

ABBV

203.23

-0.43%↓

LLY

817.59

-1.55%↓

UNH

566.44

+0.03%↑

JNJ

159.98

+0.01%↑

NVO

111.95

+0.05%↑

ABBV

203.23

-0.43%↓

LLY

817.59

-1.55%↓

UNH

566.44

+0.03%↑

JNJ

159.98

+0.01%↑

NVO

111.95

+0.05%↑

ABBV

203.23

-0.43%↓

Search

DaVita Inc

Cerrado

Sector Salud

141.12 0.72

Resumen

Variación precio

24h

Actual

Mínimo

140.58

Máximo

142.3

Métricas clave

By Trading Economics

Ingresos

-8M

215M

Ventas

70M

3.3B

P/B

Media del Sector

17.44

104.138

BPA

2.59

Margen de beneficio

6.586

Empleados

70,000

EBITDA

73M

718M

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 meses

+6.65 upside

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

-14M

12B

Apertura anterior

140.4

Cierre anterior

141.12

Noticias sobre sentimiento de mercado

By Acuity

34%

66%

105 / 389 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bearish Evidence

DaVita Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

15 jul 2024, 08:17 UTC

Charlas de Mercado

Fresenius Medical Care, DaVita Brace for Competition, Shift to Home Dialysis -- Market Talk

13 mar 2024, 13:00 UTC

Principales Noticias

Healthcare Investors Aren't Scared of Trump or Biden -- WSJ

Comparación entre iguales

Cambio de precio

DaVita Inc Esperado

Precio Objetivo

By TipRanks

6.65% repunte

Estimación a 12 meses

Media 151 USD  6.65%

Máximo 164 USD

Mínimo 145 USD

De acuerdo con 5 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para DaVita Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

5 ratings

0

Comprar

4

Mantener

1

Vender

Puntuación técnica

By Trading Central

138.59 / 156.56Soporte y Resistencia

Corto Plazo

Strong Bearish Evidence

Medio plazo

Bearish Evidence

Largo Plazo

Weak Bullish Evidence

Sentimiento

By Acuity

105 / 389 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de DaVita Inc

DaVita Inc., formerly DaVita HealthCare Partners Inc., operates one division: DaVita Kidney Care (Kidney Care). The Kidney Care division consists of the Company's United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support. The Company's segments include U.S. dialysis and related lab services and Other-Ancillary services and strategic initiatives. Its U.S. dialysis and related lab services line of business provide kidney dialysis services in the United States for patients suffering from chronic kidney failure, also known as an end-stage renal disease (ESRD). In addition, as of March 31, 2019, the Company operated or provided administrative services to 243 outpatient dialysis centers located in nine countries outside of the United States.